SGI-110. DNA methyltransferase inhibitor, oncolytic

Pharmacology, Toxicology and Pharmaceutical Science

• Decitabine 100%
• DNA Methyltransferase Inhibitor 100%
• Prodrug 50%
• Nucleoside 50%
• Active Metabolite 50%
• Clinical Trial 50%
• Liver Cell Carcinoma 50%
• Oligonucleotide 50%
• Ovary Cancer 50%
• Myelodysplastic Syndrome 50%
• Deoxyguanosine 50%
• Acute Myeloid Leukemia 50%
• Dinucleotide 50%
• Phosphodiester Bond 50%

Keyphrases

• Equivalent Effect 50%

Medicine and Dentistry

• Platinum-Resistant Ovarian Cancer 50%